ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979

News Council Says Post Series “Flawed By Sensationalism”

June 11, 1982

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

September 13, 1985

Score Distribution, Other Charts, On P01s

October 2, 1992

In Brief: UICC Honors Center Director’s Efforts To Improve Cancer Control In India

March 13, 1998